RMPT for Relapsed/Refractory Multiple Myeloma

NCT00961467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Revlimid, Melphalan, Prednisone, Thalidomide
DRUG: Revlimid, Melphalan, Prednisone, Thalidomide

Sponsor

Fondazione EMN Italy Onlus